StockWatch
·

Ugro Capital Ltd Q1 FY27 Results

UGROCAPQ1 FY27 Results
Filing
Result:Steady· Market: FlatOne-off gain

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValuevs Q4 FY26
Revenue496.94 Cr18.1%
Total Income534.63 Cr15.4%
Expenditure473.09 Cr15.6%
PBT61.54 Cr13.6%
Net Profit67.87 Cr32.8%
OPM
NPM12.69%4.60pp
EPS4.4432.5%
View full financials

Reported 98.8% PAT growth is a tax-regime one-off (deferred-tax credit) and M&A consolidation, not operating strength — like-for-like standalone PBT was essentially flat (+1.02% YoY) and consolidated PBT fell 13.6% QoQ, so the core NBFC business was in-line, not a standout.

UGRO · Q1 FY27 · THE VERDICT

Headline profit masks the organic quarter; execution intact, but transition pain persists

Ugro's reported PAT jumped 98.9%, but interest income fell 13% quarter-on-quarter, and AUM remained flat despite near-60% disbursement growth. Management reaffirmed its FY29 targets; the market fled anyway—and the data shows why.

17 Aug 2026 · 6 min read
Reported PAT

₹67.9 Cr

+98.9% YoY

Reported vs. normalized ROA

2.8% vs 2.1%

Tax reversal benefit ~70 bps

Revenue

₹496.9 Cr

+20% YoY

Interest income (QoQ)

-13%

Despite +19% YoY; reversal embedded

Ugro's Q1 result table showed a blowout: PAT nearly doubled, revenue grew 20%, and cost cuts were completed ahead of schedule. But peel back the headline and the quarter reads differently. Interest income fell 13% quarter-on-quarter despite rising 19% year-on-year—a gap that signals embedded income reversals from the Prime portfolio runoff. AUM was entirely flat despite near-60% net disbursement growth, meaning the runoff (25% annualized, faster than the 20% guided) is happening faster than management publicly signaled. Reported PAT includes a one-time tax reversal from the migration to the new tax regime; normalized (underlying) ROA is 2.1%, not the 2.8% the reported number implies. And the market has already priced this tension: the stock sold off day 1 post-result and never recovered, with foreign institutional investors fleeing (holdings crashed from 22.33% to 5.45% in a single quarter). The quarter confirms management's operational execution—but also confirms what skeptics feared: the transition is real, painful, and will take multi-quarter proof to convince the street.

The PAT story: reported vs. underlying

Reported PAT of ₹67.9 Cr is a 98.9% YoY jump, but this number embeds a one-time gain from the company's migration to the new tax regime. When you back out that benefit, the underlying ROA (and the profit it represents) is 2.1%—not the 2.8% reported. That is a vastly different picture than the headline number suggests and is the true foundation from which management is claiming a path to 3.0–3.5% ROA by FY29. The year-on-year growth story (PAT +98.9%, revenue +20%) is real, but the organic quarter is softer: interest income QoQ down 13%, which is the main red flag embedded in a good-looking revenue story.

Interest income and the earnings quality flag

Management's claims vs. what holds up

Interest income up 19% YoY driven by portfolio yield mix improvement

₹363 Cr up 19% YoY; portfolio yield 18.1% (+63 bps QoQ) via EM LAP/GROx mix shift

Supported

Opex cut substantially complete, running at ~₹490 Cr annual rate

Q1 opex ₹119 Cr (₹476 Cr annualized); down 42% QoQ from ₹217 Cr Q4. Matches ₹220 Cr reduction plan

Supported

Emerging Market LAP growing 9% QoQ with mature branches at ₹81 Lakh/month productivity

AUM ₹3,896 Cr (+9% QoQ), 317 branches. Mature cohort (>12 months) at ₹81 Lakh/month (target ₹80–85)

Supported

Interest income will grow quarter-on-quarter from Q1 base

Interest income ₹363 Cr down 13% QoQ (embedded ₹30+ Cr reversal from DSA foreclosure). Inflection timing vague

Partially answered

AUM flat (flattish transition as guided)

AUM ₹15,013 Cr flat YoY; runoff 25% vs. 20% guided. Disbursement growth 59% YoY not translating to AUM growth

Confirmed but worse than implied

The interest income story is the earnings quality flag. Yes, ₹363 Cr is up 19% year-on-year. But it fell 13% quarter-on-quarter—a reversal that confounds a good headline. The culprit: the Prime intermediated portfolio (DSA-led) is running off at 25% annualized, faster than the 20% management guided for. That runoff embeds income reversals—off-balance sheet contracts that recognized income upfront now reverse as loans foreclose. Management quantified it as ₹30+ Cr embedded in the Q1 income statement. On-balance sheet interest earning assets are growing (the higher-yielding EM LAP and GROx pools), but they're not yet large enough to overcome the DSA foreclosure tail. Portfolio yield improved 63 basis points to 18.1%, which is healthy; but the absolute quantum of interest income QoQ still fell. This is the structural transition pain: you're shifting from a low-yield, capital-light intermediation model to a higher-yield, capital-intensive direct origination model, and there's a valley in the middle.

The co-lend/direct assignment (DA) income bucket tells the same story: ₹75 Cr in Q1 vs. ₹155 Cr in Q4, a 52% QoQ decline. This is intentional runoff—management is explicitly de-risking the capital-light tail—but it also embeds further income reversals. Co-lend declined from 24% of total income to 14%, and management is guiding it to stabilize at this 14% run rate through FY27, then decline to 4% by end-FY28. If that plan holds, by end-FY29 the portfolio will be nearly 85% direct origination (EM LAP and GROx), with profitability driven by cash interest, not capital reversals. But in the near term (FY27–FY28), this transition creates earnings volatility that the headline numbers don't capture.

What changed on this call

Shifts vs. prior guidance
  • EM LAP and GROx beating 25% CAGR targets (9% QoQ and 32% QoQ vs. guidance)

  • Prime runoff accelerating: 25% annualized vs. 20% guided (shortens transition but increases near-term volatility)

  • Opex reduction fully delivered; Q1 annualized rate ₹476 Cr vs. ₹490 Cr guidance

  • Co-lend income stabilizing at 14% run rate for FY27 (as guided; decline to 4% by Q4 FY28 on track)

  • July 2026 milestone: ₹1,000 Cr monthly disbursement achieved (validates dual-engine scaling thesis)

  • FY29 targets reaffirmed (25% CAGR, 85% AUM mix, 3.0–3.5% ROA). Intermediate guidance (FY27–28) remains vague

The most material shift is acceleration of Prime runoff: 25% annualized vs. the 20% management guided. This is happening faster than publicly signaled, which compresses the transition timeline but also increases the risk of extended flatness or near-term AUM volatility. The growth engines (EM LAP and GROx) are outpacing targets, which is credible and good. But the faster runoff means the net of those two forces is still zero—AUM flat despite 59% net disbursement growth. Management's rationale is that faster foreclosure of the DSA portfolio is intentional (collection infrastructure, avoiding negative carry, income reversal risk)—but it also signals that the customer base in that segment is stressing faster than implied. This is a data point to watch for early warning on credit quality elsewhere.

How the street is positioned (and what it's telling you)

Post-result price action: The stock fell 1.36% on day 1 post-announcement, 2.15% by day 3, and 1.12% by day 5. The sell-off held; there was no recovery. This is the market's own verdict on the print: good headline numbers, but not convinced on intermediate execution. The stock is now down 50.85% from its all-time high of ₹189.92, trading below all moving averages (SMA20 ₹95.3, SMA50 ₹96.16, SMA200 ₹125.73). RSI is neutral at 42.1, suggesting the stock isn't yet oversold—a warning that further downside may be possible if the company misses on intermediate guidance.

Foreign institutional exodus: The most damning signal is the FII collapse. Institutional ownership crashed from 22.33% (Q4 FY26) to 5.45% (Q1 FY27)—a 16.88 percentage-point drop in a single quarter, coinciding with the result announcement. This isn't gradual profit-taking; it's a rout. Institutions exited just as the company reaffirmed its FY29 guidance. The message is unambiguous: the street doesn't believe the intermediate thesis and doesn't want to hold through the transition pain. DII ownership barely budged (1.68% → 1.85%), meaning domestic institutions aren't stepping in either. At ₹93.34, the stock isn't attracting buyers at any institutional tier.

Valuation and opportunity cost: The stock is trading at roughly 0.5x book value, by management's own acknowledgement during the Q&A. This reflects investor skepticism on three fronts: (1) the ROA inflection from 2.1% to 3.5% is unproven at scale and multi-quarter; (2) intermediate guidance is absent, leaving investors to extrapolate; (3) FII exodus signals macro/sentiment headwinds (management blamed PE fund exits, Iran war timing on F&B merchants, and mutual fund market-cap entry biases—all valid, but institutional money doesn't wait for macro clarity). For a holder, this means the path to 0.7x or 1.0x book is contingent on Q2–Q3 delivering visibility on AUM inflection and normalized ROA trending toward 2.5%+.

The bull-bear ledger

Two-sided view
  • Growth engines (EM LAP, GROx) beating 25% CAGR targets; 9% and 32% QoQ growth is strong

  • Opex cut fully delivered (₹220 Cr reduction, Q1 at annualized run rate); cost-base reset complete

  • GNPA stable at 2.1–2.6% across engines; within modeled peak expectations. Early warning systems (post-Iran war daily monitoring) in place

  • Portfolio yield improved 63 bps to 18.1% via mix shift; higher-yielding segments (EM LAP 18.5%, GROx 26%) now 46% of AUM

  • July 2026: ₹1,000 Cr/month disbursement milestone validates dual-engine capacity and self-funding thesis

  • Reported PAT inflated by one-time tax reversal; normalized profit basis only 2.1% ROA, not 2.8%

  • AUM flat despite 59% disbursement growth; runoff at 25% vs. 20% guided accelerating transition but masking underlying growth

  • Interest income down 13% QoQ despite 20% YoY revenue growth; ₹30+ Cr embedded reversals from DSA foreclosure clouding organic momentum

  • Intermediate guidance sparse (FY27–28 absent); only FY29 targets articulated. Management vague on interest income inflection timing

  • FII fled 16.88pp in a single quarter during result announcement; institutions aren't convinced by the pitch

  • Execution risks explicitly named (branch productivity ramp, GROx credit expansion, runoff acceleration) but mitigation conditional on 'if things go as expected'

Risks, ranked by severity for a holder

What could derail the FY29 thesis

Credit quality deterioration: EM LAP GNPA 2.1% and GROx 2.1% (peaks expected 3.5–4% and <3% respectively at 18-month seasoning)

High

If both breach peak expectations, credit cost could exceed 1.5–2% guidance, compressing margins by 50–100 bps and delaying ROA inflection. GNPA breaches would also force regulatory provisioning, tightening capital.

Prime portfolio runoff acceleration: Running at 25% vs. 20% guided; if >30%, income reversal pressure could offset operational improvements

High

Faster runoff = more embedded reversals, lower reported profit in FY27–28. Combined with slower on-balance sheet growth, this extends AUM flatness and delays the inflection management is promising.

AUM inflection failure: Currently flat despite 59% disbursement growth. If runoff doesn't moderate or disbursement growth doesn't sustain, AUM could stay flat or decline through FY27

High

AUM is the denominator for ROA expansion. If AUM flatness extends beyond H2 FY27, the 3.5% ROA target by FY29 becomes mathematically harder to achieve.

Interest income structural floor: QoQ decline (-13%) from DSA runoff and lack of on-balance sheet asset growth. If inflection doesn't occur in Q2–Q3, management's 'Q1 is the base' narrative loses credibility

Medium

Interest income is the largest revenue bucket (73% of total). Structural decline undermines the case for absolute profit growth, even if margins expand.

Branch productivity ramp failure: 145 EM LAP branches <6 months old must scale to ₹75–80 Lakh/month by 12-month mark. If productivity stays at ₹30–40 Lakh/month longer, AUM growth gets delayed

Medium

This is the execution lever that determines whether disbursement growth translates to AUM growth. Miss this, and transition extends into FY28.

GROx credit expansion risk: Platform expanding into longer-tenure (18–24 months), higher-ticket marketplace loans. Unproven credit quality at scale and longer duration

Medium

Current GROx model relies on velocity and short tenure (12–13 months). Expanding into longer assets increases credit risk exposure and duration mismatch if funding is short-term.

The debate

What to watch in Q2–Q3 (the inflection signals)
  • 1 · Interest income trajectory (Q2 FY27)

    Did it stabilize or reverse again? Management claimed 'Q1 is the base, interest income will grow QoQ from here.' Q2 data will confirm or contradict. If interest income is down again QoQ in Q2, the credibility of management's near-term guidance will be in question.

  • 2 · AUM growth inflection (Q2–Q3 FY27)

    Will AUM finally turn positive, or does it stay flat? Currently flat ₹15,013 Cr despite 59% disbursement growth (runoff at 25% vs. 20% guided). If AUM remains flat into Q3, the transition timeline extends into FY28, and FY29 targets face credibility loss.

  • 3 · Credit quality (EM LAP, GROx GNPA, Q2–Q3)

    Are we tracking within modeled peaks (EM LAP 3.5–4%, GROx <3% at full seasoning)? If GNPA breaches expectations by Q3, credit costs will exceed 1.5–2% guidance and compress the ROA pathway. Early warning: post-Iran war spike in F&B merchant defaults is being monitored daily.

  • 4 · FII positioning and institutional confidence

    Will FII stabilize or continue exiting? Ownership at 5.45% is near historical low. If DII or FII starts accumulating in Q2–Q3, it signals street is coming back to the story. If ownership stays flat/declines, it confirms institutions aren't convinced by current guidance.

Ugro's Q1 result is a quarter of operational execution masked by transition pain. The company hit its targets on cost, growth engines, and credit quality. But the underlying business is showing stress: flat AUM despite 60% disbursement growth, QoQ interest income decline despite YoY growth, and normalized profit lower than reported. Management's reaffirmation of FY29 targets without intermediate guidance is a credibility wager, not a certainty. The market's harsh verdict (FII exodus, 50% drawdown, persistent sell-off) isn't macro noise; it's the street correctly pricing execution risk and demanding proof before re-rating valuation.

The honest read: This is a Hold. The execution on stated priorities (growth, cost, credit) is credible, but the quarter proves that the transition will take multiple quarters to resolve. The stock at ₹93.34 (0.5x book) isn't cheap; it's fairly valued for an unproven inflection story. If Q2–Q3 show AUM inflection and interest income stabilizing, the re-rating from 0.5x book to 0.7–1.0x would be justified. Until then, there's no edge in being early.

The single number to track: normalized ROA (not reported ROA). The reported figure is inflated by a one-time tax reversal; the true metric is the 2.1% base. Watch for it to trend toward 2.5%+ by Q4 FY27. If normalized ROA is still <2.3% by Q3 FY27, the FY29 3.5% target loses credibility, and the stock likely re-rates lower.

Informational and educational content only. Not investment advice.

Ugro Capital Ltd (UGROCAP) Q1 FY27 Results, Transcript & Analysis — StockWatch